Table 2.
Signs and symptoms | Lassa (n = 47) n, (%) | Fever (n = 29) n, (%) | Control (n = 71) n, (%) | Overall p-valuea,b | p-valuea,c | p-valuea,d |
---|---|---|---|---|---|---|
Weight loss | 27 (57) | 10 (34) | 34 (48) | 0.146 | 0.052 | 0.309 |
Paresthesia | 11 (23) | 5 (17) | 13 (18) | 0.733 | 0.522 | 0.501 |
Difficulty with balance/walking | 26 (55) | 11 (38) | 14 (20) | <0.001 | 0.141 | <0.001 |
Tremor | 20 (43) | 9 (31) | 17 (24) | 0.105 | 0.315 | 0.033 |
Lymphadenopathy | 9 (19) | 2 (7) | 5 (7) | 0.104 | 0.140 | 0.046 |
Headache | 35 (74) | 16 (55) | 47 (66) | 0.223 | 0.082 | 0.339 |
Hair loss | 15 (32) | 4 (14) | 5 (7) | 0.002 | 0.076 | <0.001 |
Lightheadedness | 25 (53) | 13 (45) | 21 (30) | 0.018 | 0.479 | 0.010 |
Fainting | 2 (4) | 2 (7) | 5 (7) | 0.800 | 0.616 | 0.530 |
Vertigo | 10 (21) | 8 (28) | 9 (13) | 0.212 | 0.530 | 0.213 |
Seizures | 1 (2) | 2 (7) | 3 (4) | 0.593 | 0.300 | 0.538 |
Hallucinations | 8 (17) | 5 (17) | 9 (13) | 0.735 | 0.980 | 0.510 |
Hearing loss | 8 (17) | 2 (7) | 1 (1) | 0.005 | 0.205 | 0.002 |
Tinnitus | 13 (28) | 10 (34) | 15 (21) | 0.369 | 0.529 | 0.414 |
Blurred vision | 9 (19) | 6 (21) | 9 (13) | 0.505 | 0.870 | 0.338 |
Difficulty speaking | 9 (19) | 6 (21) | 1 (1) | <0.001 | 0.870 | <0.001 |
Difficulty thinking clearly | 6 (13) | 1 (3) | 5 (7) | 0.319 | 0.172 | 0.295 |
Difficulty swallowing | 8 (17) | 3 (10) | 12 (17) | 0.658 | 0.422 | 0.986 |
Change in the taste of food | 18 (38) | 10 (34) | 12 (17) | 0.020 | 0.738 | 0.008 |
Change in smell | 7 (15) | 6 (21) | 7 (10) | 0.355 | 0.514 | 0.902 |
Hospitalized since illness | 5 (11) | 8 (28) | 5 (7) | 0.028 | 0.057 | 0.492 |
α level required for significance adjusted through Bonferroni correction to 0.0023.
Overall p-value of logistic regression model using asymptotic Chi-squared test.
Pearson’s Chi-squared test comparing Lassa fever survivors and febrile controls
Pearson’s Chi-squared test comparing Lassa fever survivors and matched controls